Kany, Shinwan
Brachmann, Johannes
Lewalter, Thorsten
Akin, Ibrahim
Sievert, Horst
Zeymer, Uwe
Ledwoch, Jakob
Ince, Hüseyin
Thomas, Dierk
Hochadel, Matthias
Senges, Jochen
Kirchhof, Paulus
Rillig, Andreas
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 12 January 2021
Accepted: 17 May 2021
First Online: 27 May 2021
Declarations
:
: SK, JL: none<b>;</b> JB: study support and speaker fees from Boston Scientific, Abbott, Medtronic; TL: modest speaker fees: Abbott, Boston Scientific, Lifetech; HS: reports study honoraria to institution, travel expenses, consulting fees1 < 25. 000 €: 4tech Cardio, Abbott, Ablative Solutions, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, Cardiac Success, Cardimed, Celonova, Contego, Croivalve, CVRx, Dinova, Edwards, Endobar, Endologix, Endomatic, Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, K2, Lifetech, Magenta, Maquet Getinge Group, Medtronic, Metavention, Mitralix, Mokita, NXT Biomedical, Occlutech, Recor, Renal Guard, Terumo, Trisol, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, HI: speaker fees Boston Scientific, Abbott; DT: lecture fees/honoraria from Bayer Vital, Boehringer Ingelheim Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer Pharma, Sanofi-Aventis, St. Jude Medical, ZOLL CMS; MH, JS: unrestricted grant from Boston Scientific; PK: rresearch support from EU, BHF, Leducq Foundation, Medical Research Council (UK), and DZHK; AR: travel grants/lecture/consultant fees from Medtronik, Ablamap, Biosense webster, KODEX-EPD, Cardiofocus, Böhringer Ingelheim.
: Ethics committee of the Rhineland‐Palatinate State Medical Council (Landesärztekammer Rheinland‐Pfalz) approved the study (837.173.14 (9412-F), 25.06.2014).
: Given by all co-authors.